| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 9 |
| 1 | CLINDAMYCIN | 8 |
| 2 | CLINDAMYCIN PHOSPHATE | 8 |
| 3 | ADALIMUMAB | 7 |
| 4 | INFLIXIMAB | 7 |
| 5 | ETANERCEPT | 6 |
| 6 | LEVONORGESTREL | 6 |
| 7 | METHOTREXATE | 6 |
| 8 | METHOTREXATE SODIUM | 6 |
| 9 | RITUXIMAB | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE | 8 | 0.0014 |
| 1 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 2 | SAXAGLIPTIN | 1 | 0.0007 |
| 3 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 4 | CLINDAMYCIN HYDROCHLORIDE | 2 | 0.0006 |
| 5 | DEFLAZACORT | 1 | 0.0004 |
| 6 | DESOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0003 |
| 7 | OCTREOTIDE ACETATE | 9 | 0.0003 |
| 8 | TRANEXAMIC ACID | 2 | 0.0002 |
| 9 | PERINDOPRIL ERBUMINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 1 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 9 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |